# Liquidia Corp (LQDA)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/liquidia-corp/ JSON: https://steadybase.io/company/liquidia-corp.json Checked Nov 10, 2026. Latest filing read: Aug 12, 2026.

## Company

- Legal name: Liquidia Corp
- Ticker: LQDA (Nasdaq)
- SEC CIK: 0001819576
- Industry: Pharmaceutical Preparations (SIC 2834)
- Headquarters: Morrisville, NC
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer
- Website: liquidia.com
- LinkedIn: https://www.linkedin.com/company/liquidia-corporation
- Next earnings date: Nov 10, 2026

## Key facts

- Revenue: $158.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/0001104659-26-023804-index.html
- Operating income: -$51.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/0001104659-26-023804-index.html
- Net income: -$68.9M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/0001104659-26-023804-index.html
- SG&A: $157.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/0001104659-26-023804-index.html
- Employees: 216 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/lqda-20251231x10k.htm
- Shares outstanding: 89,508,891 as of Jul 29, 2026 (10-Q filed Aug 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926094410/0001104659-26-094410-index.html
- Auditor: Pricewaterhousecoopers LLP, Raleigh, North Carolina, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/lqda-20251231x10k.htm

## Business

We are a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases such as pulmonary arterial hypertension (“PAH”) and pulmonary hypertension associated with interstitial lung disease (“PH-ILD”). We operate through our wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC, formerly known as RareGen.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/lqda-20251231x10k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $158.3M | -$51.4M | -$68.9M | $157.2M |
| Dec 31, 2024 | $14.0M | -$121.3M | -$128.3M | $81.6M |
| Dec 31, 2023 | $17.5M | -$73.4M | -$78.5M | $44.7M |
| Dec 31, 2022 | $15.9M | -$38.8M | -$41.0M | $32.4M |
| Dec 31, 2021 | $12.9M | -$33.8M | -$34.6M | $23.1M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/liquidia-corp.json

## Officers and directors

- Roger Jeffs, Chief Executive Officer. LinkedIn: https://linkedin.com/in/roger-jeffs-b816b45. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926083619/0001104659-26-083619-index.htm
- Michael Kaseta, CFO and COO. LinkedIn: https://linkedin.com/in/mike-kaseta-b628b83. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926083620/0001104659-26-083620-index.htm
- Sarah Krepp, Chief Human Resource Officer. Source: Form 4 filed Sep 3, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926105074/0001104659-26-105074-index.htm
- Jason Adair, Chief Business Officer. Source: Form 4 filed Aug 25, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926100826/0001104659-26-100826-index.htm
- Rajeev Saggar, Chief Medical Officer. LinkedIn: https://linkedin.com/in/rajeev-saggar-0b289486. Source: Form 4 filed Aug 19, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926098862/0001104659-26-098862-index.htm
- Dana Boyle, Chief Accounting Officer. LinkedIn: https://www.linkedin.com/in/boyled. Source: Form 4 filed Jul 29, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926088173/0001104659-26-088173-index.htm
- Russell Schundler, General Counsel. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926083617/0001104659-26-083617-index.htm
- Sanjeev Khindri, Chief Development Officer. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926083621/0001104659-26-083621-index.htm
- Scott Moomaw, Chief Commercial Officer. LinkedIn: https://linkedin.com/in/scott-moomaw. Source: Form 4 filed Jul 14, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926083615/0001104659-26-083615-index.htm
- Rajeev Saggar, M.D, Named in proxy. Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926048597/tm261471-1_def14a.htm
- Roger A. Jeffs, Ph.D., Board member (per proxy). Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926048597/tm261471-1_def14a.htm
- Sanjeev Khindri, MB, ChB, Named in proxy. Source: DEF 14A filed Apr 24, 2026, https://www.sec.gov/Archives/edgar/data/1819576/000110465926048597/tm261471-1_def14a.htm

## Recent 8-K events

- Oct 14, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/tm2627557d1_8k.htm
- Sep 30, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926112420/tm2626740d1_8k.htm
- Sep 3, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926104929/tm2624724d1_8k.htm
- Aug 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926094411/tm2622888d1_8k.htm
- Jun 17, 2026: Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926075177/tm2618171d1_8k.htm
- Jun 8, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926071407/tm2617139d1_8k.htm
- May 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926058234/tm2614109d1_8k.htm
- Mar 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023794/tm267579d3_8k.htm
- Jan 9, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926002306/tm262716d1_8k.htm
- Nov 3, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465925105199/tm2530004d1_8k.htm

## Insider trades (Form 4)

- Oct 26, 2026: Dana Boyle (Chief Accounting Officer) sold 1,581 shares, about $68,283. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926119656/0001104659-26-119656-index.htm
- Oct 26, 2026: Jason Adair (Chief Business Officer) sold 688 shares, about $29,715. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926119651/0001104659-26-119651-index.htm
- Oct 12, 2026: Russell Schundler (General Counsel) sold 13,692 shares, about $389,948. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115650/0001104659-26-115650-index.htm
- Oct 12, 2026: Rajeev Saggar (Chief Medical Officer) sold 9,218 shares, about $262,529. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115649/0001104659-26-115649-index.htm
- Oct 12, 2026: Scott Moomaw (Chief Commercial Officer) sold 8,863 shares, about $252,418. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115648/0001104659-26-115648-index.htm
- Oct 12, 2026: Sarah Krepp (Chief Human Resource Officer) sold 5,245 shares, about $149,378. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115647/0001104659-26-115647-index.htm
- Oct 12, 2026: Sanjeev Khindri (Chief Development Officer) sold 1,101 shares, about $31,356. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115646/0001104659-26-115646-index.htm
- Oct 12, 2026: Michael Kaseta (CFO and COO) sold 18,938 shares, about $539,354. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115644/0001104659-26-115644-index.htm
- Oct 12, 2026: Roger Jeffs (Chief Executive Officer) sold 32,744 shares, about $932,549. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115642/0001104659-26-115642-index.htm
- Oct 12, 2026: Dana Boyle (Chief Accounting Officer) sold 5,892 shares, about $167,804. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115641/0001104659-26-115641-index.htm
- Oct 12, 2026: Jason Adair (Chief Business Officer) sold 7,301 shares, about $207,932. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115640/0001104659-26-115640-index.htm
- Oct 5, 2026: Stephen M. Bloch (Director) sold 235,477 shares, about $6.4M. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926114372/0001104659-26-114372-index.htm
- Sep 14, 2026: Raman Singh (Director) sold 17,492 shares, about $1.2M. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926107942/0001104659-26-107942-index.htm
- Sep 1, 2026: Sarah Krepp (Chief Human Resource Officer) sold 274 shares, about $18,566. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926105074/0001104659-26-105074-index.htm
- Aug 21, 2026: Jason Adair (Chief Business Officer) sold 73,631 shares, about $5.1M. Source: https://www.sec.gov/Archives/edgar/data/1819576/000110465926100826/0001104659-26-100826-index.htm

## Latest filings

- 8-K filed Oct 14, 2026: https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/tm2627557d1_8k.htm
- 10-K filed Mar 5, 2026: https://www.sec.gov/Archives/edgar/data/1819576/000110465926023804/lqda-20251231x10k.htm
- 10-Q filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/1819576/000110465926094410/lqda-20260630x10q.htm
- DEF 14A filed Apr 24, 2026: https://www.sec.gov/Archives/edgar/data/1819576/000110465926048597/tm261471-1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/